Furthermore, radiotherapy and some chemotherapeutics (e.g., mitomycin C and cisplatin) that increase PD-L1 expression on tumor cells sensitize lung cancer to α-PD-L1 therapy [15,18,19]. This evidence concerns the gene CD274 and lung cancer.